ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,250, issued on May 13, was assigned to ANTAG THERAPEUTICS APS (Copenhagen N, Denmark).
"Modified GIP peptide analogues" was invented by Alexander Hovard Sparre-Ulrich (Copenhagen N, Denmark), Bjorn Behrens Sivertsen (Copenhagen S, Denmark), Ditte Riber (Bronshoj, Denmark) and Mette Marie Rosenkilde (Hellerup, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are glucose-dependent insulinotropic peptide (GIP)-derived peptide analogues which are antagonists of the GIP receptor. These GIP peptide analogues are modified by comprising one or more individual amino acid substitutions and are fatty acid conjugated with/without a linker, so to...